Martin Legault Files Early Warning Report

NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Feb. 27, 2020 (GLOBE NEWSWIRE) — On February 25, 2020, Mr. Martin Legault, Fiducie Famille Martin Legault, and a holding corporation, 8574197 Canada Inc. wholly owned by Mr. Legault, acquired an aggregate of 25,168,000 common shares (the “Common Shares”) in the share capital of Premier Health of America Inc. (formerly known as Physinorth Acquisition Corporation Inc.) (the “Issuer”) pursuant to a Qualifying Transaction (the “Transaction”) between the Issuer and 6150977 Canada Inc. and its subsidiary Excel Health Inc., 8961760 Canada Inc. and 10544485 Canada Inc., a group of privately-held Canadian companies, doing business as Groupe Premier Soin (collectively, the “GPS Entities”), the whole as more fully described in the Issuer’s information circular dated October 21, 2019 filed on the Issuer’s SEDAR profile (the “Information Circular”). Mr. Legault, Fiducie Famille Martin Legault, and 8574197 Canada Inc. acquired the 25,168,000 Common Shares at a price of $0.25 per Common Share in exchange for common shares held in the capital of the GPS Entities.Prior to completion of the Transaction, Mr. Legault had ownership or control of no securities of the Issuer. As a result of the Transaction, Mr. Legault has direct and indirect beneficial ownership of 25,168,000 Common Shares of the Issuer, representing approximately 66.54% of the issued and outstanding Common Shares of the Issuer as of the date of the closing of the Transaction.Mr. Legault directly and indirectly acquired the Common Shares for investment purposes. Depending upon the circumstances, Mr. Legault may, from time to time, acquire additional securities of the Issuer or dispose of all or a portion of the securities of the Issuer previously acquired.An early warning report containing additional information with respect to the foregoing matters will be filed under the Issuer’s SEDAR profile at www.sedar.com.Further information or a copy of the early warning report may be obtained by contacting:

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.